nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—coronary artery disease—type 2 diabetes mellitus	0.263	0.627	CtDrD
Timolol—ADRB3—type 2 diabetes mellitus	0.24	1	CbGaD
Timolol—hypertension—type 2 diabetes mellitus	0.157	0.374	CtDrD
Timolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0288	0.136	CbGbCtD
Timolol—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0176	0.0827	CbGbCtD
Timolol—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0165	0.0777	CbGbCtD
Timolol—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0157	0.0738	CbGbCtD
Timolol—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0141	0.0661	CbGbCtD
Timolol—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0141	0.0661	CbGbCtD
Timolol—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.013	0.061	CbGbCtD
Timolol—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0125	0.0589	CbGbCtD
Timolol—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0113	0.0533	CbGbCtD
Timolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0107	0.0502	CbGbCtD
Timolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00986	0.0464	CbGbCtD
Timolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0081	0.0381	CbGbCtD
Timolol—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00779	0.0366	CbGbCtD
Timolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00776	0.0365	CbGbCtD
Timolol—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0072	0.0338	CbGbCtD
Timolol—CYP2C19—Losartan—type 2 diabetes mellitus	0.00658	0.0309	CbGbCtD
Timolol—ABCB1—Glyburide—type 2 diabetes mellitus	0.00581	0.0273	CbGbCtD
Timolol—ABCB1—Losartan—type 2 diabetes mellitus	0.00531	0.025	CbGbCtD
Timolol—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00317	0.658	CbGeAlD
Timolol—Bupranolol—ADRB3—type 2 diabetes mellitus	0.00101	1	CrCbGaD
Timolol—ADRB3—adipose tissue—type 2 diabetes mellitus	0.000427	0.0888	CbGeAlD
Timolol—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000198	0.0412	CbGeAlD
Timolol—ADRB1—adipose tissue—type 2 diabetes mellitus	0.000175	0.0363	CbGeAlD
Timolol—CYP2C19—liver—type 2 diabetes mellitus	9.81e-05	0.0204	CbGeAlD
Timolol—ABCB1—islet of Langerhans—type 2 diabetes mellitus	9.18e-05	0.0191	CbGeAlD
Timolol—CYP2D6—kidney—type 2 diabetes mellitus	9.03e-05	0.0188	CbGeAlD
Timolol—ABCB1—retina—type 2 diabetes mellitus	7.85e-05	0.0163	CbGeAlD
Timolol—ABCB1—nephron tubule—type 2 diabetes mellitus	7.39e-05	0.0153	CbGeAlD
Timolol—ABCB1—cardiovascular system—type 2 diabetes mellitus	6.64e-05	0.0138	CbGeAlD
Timolol—ABCB1—kidney—type 2 diabetes mellitus	6.49e-05	0.0135	CbGeAlD
Timolol—ABCB1—pancreas—type 2 diabetes mellitus	6.45e-05	0.0134	CbGeAlD
Timolol—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.32e-05	0.0131	CbGeAlD
Timolol—ABCB1—adipose tissue—type 2 diabetes mellitus	5.85e-05	0.0122	CbGeAlD
Timolol—CYP2D6—liver—type 2 diabetes mellitus	5.71e-05	0.0119	CbGeAlD
Timolol—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	4.47e-05	0.000505	CcSEcCtD
Timolol—Oedema—Metformin—type 2 diabetes mellitus	4.47e-05	0.000504	CcSEcCtD
Timolol—Tinnitus—Ramipril—type 2 diabetes mellitus	4.47e-05	0.000504	CcSEcCtD
Timolol—Hypertension—Irbesartan—type 2 diabetes mellitus	4.46e-05	0.000504	CcSEcCtD
Timolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	4.45e-05	0.000503	CcSEcCtD
Timolol—Angioedema—Losartan—type 2 diabetes mellitus	4.44e-05	0.000502	CcSEcCtD
Timolol—Infection—Metformin—type 2 diabetes mellitus	4.44e-05	0.000501	CcSEcCtD
Timolol—Insomnia—Valsartan—type 2 diabetes mellitus	4.44e-05	0.000501	CcSEcCtD
Timolol—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	4.42e-05	0.000499	CcSEcCtD
Timolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	4.41e-05	0.000497	CcSEcCtD
Timolol—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	4.4e-05	0.000497	CcSEcCtD
Timolol—Arthralgia—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000497	CcSEcCtD
Timolol—Chest pain—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000497	CcSEcCtD
Timolol—Myalgia—Irbesartan—type 2 diabetes mellitus	4.4e-05	0.000497	CcSEcCtD
Timolol—Shock—Metformin—type 2 diabetes mellitus	4.4e-05	0.000496	CcSEcCtD
Timolol—Insomnia—Orlistat—type 2 diabetes mellitus	4.39e-05	0.000495	CcSEcCtD
Timolol—Anxiety—Irbesartan—type 2 diabetes mellitus	4.39e-05	0.000495	CcSEcCtD
Timolol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	4.38e-05	0.000495	CcSEcCtD
Timolol—Nervous system disorder—Metformin—type 2 diabetes mellitus	4.38e-05	0.000495	CcSEcCtD
Timolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.38e-05	0.000494	CcSEcCtD
Timolol—Vertigo—Losartan—type 2 diabetes mellitus	4.37e-05	0.000493	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.37e-05	0.000493	CcSEcCtD
Timolol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.37e-05	0.000493	CcSEcCtD
Timolol—Somnolence—Valsartan—type 2 diabetes mellitus	4.36e-05	0.000492	CcSEcCtD
Timolol—Syncope—Losartan—type 2 diabetes mellitus	4.36e-05	0.000492	CcSEcCtD
Timolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.36e-05	0.000492	CcSEcCtD
Timolol—Discomfort—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.000491	CcSEcCtD
Timolol—Skin disorder—Metformin—type 2 diabetes mellitus	4.34e-05	0.00049	CcSEcCtD
Timolol—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000488	CcSEcCtD
Timolol—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.32e-05	0.000488	CcSEcCtD
Timolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.32e-05	0.000488	CcSEcCtD
Timolol—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.32e-05	0.000487	CcSEcCtD
Timolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.3e-05	0.000486	CcSEcCtD
Timolol—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.3e-05	0.000486	CcSEcCtD
Timolol—Palpitations—Losartan—type 2 diabetes mellitus	4.3e-05	0.000485	CcSEcCtD
Timolol—Nausea—Glimepiride—type 2 diabetes mellitus	4.29e-05	0.000484	CcSEcCtD
Timolol—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000483	CcSEcCtD
Timolol—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.28e-05	0.000482	CcSEcCtD
Timolol—Nausea—Sitagliptin—type 2 diabetes mellitus	4.27e-05	0.000482	CcSEcCtD
Timolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.27e-05	0.000482	CcSEcCtD
Timolol—Asthenia—Glyburide—type 2 diabetes mellitus	4.27e-05	0.000482	CcSEcCtD
Timolol—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.27e-05	0.000482	CcSEcCtD
Timolol—Anorexia—Metformin—type 2 diabetes mellitus	4.26e-05	0.000481	CcSEcCtD
Timolol—Cough—Losartan—type 2 diabetes mellitus	4.24e-05	0.000479	CcSEcCtD
Timolol—Urticaria—Gliclazide—type 2 diabetes mellitus	4.24e-05	0.000479	CcSEcCtD
Timolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.24e-05	0.000478	CcSEcCtD
Timolol—Alopecia—Ramipril—type 2 diabetes mellitus	4.23e-05	0.000478	CcSEcCtD
Timolol—Fatigue—Valsartan—type 2 diabetes mellitus	4.23e-05	0.000478	CcSEcCtD
Timolol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.22e-05	0.000477	CcSEcCtD
Timolol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.22e-05	0.000477	CcSEcCtD
Timolol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.22e-05	0.000476	CcSEcCtD
Timolol—Oedema—Irbesartan—type 2 diabetes mellitus	4.22e-05	0.000476	CcSEcCtD
Timolol—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.22e-05	0.000476	CcSEcCtD
Timolol—Pruritus—Glyburide—type 2 diabetes mellitus	4.21e-05	0.000475	CcSEcCtD
Timolol—Mental disorder—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000474	CcSEcCtD
Timolol—Infection—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000473	CcSEcCtD
Timolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.19e-05	0.000473	CcSEcCtD
Timolol—Fatigue—Orlistat—type 2 diabetes mellitus	4.18e-05	0.000472	CcSEcCtD
Timolol—Hypotension—Metformin—type 2 diabetes mellitus	4.18e-05	0.000471	CcSEcCtD
Timolol—Erythema—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000471	CcSEcCtD
Timolol—Malnutrition—Ramipril—type 2 diabetes mellitus	4.17e-05	0.000471	CcSEcCtD
Timolol—Shock—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000468	CcSEcCtD
Timolol—Pain—Orlistat—type 2 diabetes mellitus	4.15e-05	0.000468	CcSEcCtD
Timolol—Arthralgia—Losartan—type 2 diabetes mellitus	4.14e-05	0.000467	CcSEcCtD
Timolol—Myalgia—Losartan—type 2 diabetes mellitus	4.14e-05	0.000467	CcSEcCtD
Timolol—Chest pain—Losartan—type 2 diabetes mellitus	4.14e-05	0.000467	CcSEcCtD
Timolol—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.14e-05	0.000467	CcSEcCtD
Timolol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.14e-05	0.000467	CcSEcCtD
Timolol—Anxiety—Losartan—type 2 diabetes mellitus	4.13e-05	0.000466	CcSEcCtD
Timolol—ABCB1—liver—type 2 diabetes mellitus	4.1e-05	0.00853	CbGeAlD
Timolol—Rash—Bromocriptine—type 2 diabetes mellitus	4.1e-05	0.000463	CcSEcCtD
Timolol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.1e-05	0.000463	CcSEcCtD
Timolol—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.1e-05	0.000462	CcSEcCtD
Timolol—Tension—Ramipril—type 2 diabetes mellitus	4.09e-05	0.000462	CcSEcCtD
Timolol—Discomfort—Losartan—type 2 diabetes mellitus	4.09e-05	0.000462	CcSEcCtD
Timolol—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.08e-05	0.000461	CcSEcCtD
Timolol—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.08e-05	0.00046	CcSEcCtD
Timolol—Headache—Bromocriptine—type 2 diabetes mellitus	4.08e-05	0.00046	CcSEcCtD
Timolol—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.07e-05	0.00046	CcSEcCtD
Timolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.07e-05	0.000459	CcSEcCtD
Timolol—Nervousness—Ramipril—type 2 diabetes mellitus	4.05e-05	0.000457	CcSEcCtD
Timolol—Dry mouth—Losartan—type 2 diabetes mellitus	4.05e-05	0.000457	CcSEcCtD
Timolol—Anorexia—Irbesartan—type 2 diabetes mellitus	4.02e-05	0.000454	CcSEcCtD
Timolol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.01e-05	0.000453	CcSEcCtD
Timolol—Paraesthesia—Metformin—type 2 diabetes mellitus	4.01e-05	0.000453	CcSEcCtD
Timolol—Confusional state—Losartan—type 2 diabetes mellitus	4e-05	0.000452	CcSEcCtD
Timolol—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4e-05	0.000451	CcSEcCtD
Timolol—Dyspnoea—Metformin—type 2 diabetes mellitus	3.99e-05	0.00045	CcSEcCtD
Timolol—Somnolence—Metformin—type 2 diabetes mellitus	3.97e-05	0.000448	CcSEcCtD
Timolol—Oedema—Losartan—type 2 diabetes mellitus	3.97e-05	0.000448	CcSEcCtD
Timolol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	3.97e-05	0.000448	CcSEcCtD
Timolol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	3.97e-05	0.000448	CcSEcCtD
Timolol—Infection—Losartan—type 2 diabetes mellitus	3.94e-05	0.000445	CcSEcCtD
Timolol—Hypotension—Irbesartan—type 2 diabetes mellitus	3.94e-05	0.000445	CcSEcCtD
Timolol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	3.94e-05	0.000444	CcSEcCtD
Timolol—Dyspepsia—Metformin—type 2 diabetes mellitus	3.93e-05	0.000444	CcSEcCtD
Timolol—Shock—Losartan—type 2 diabetes mellitus	3.91e-05	0.000441	CcSEcCtD
Timolol—Urticaria—Valsartan—type 2 diabetes mellitus	3.9e-05	0.00044	CcSEcCtD
Timolol—Nervous system disorder—Losartan—type 2 diabetes mellitus	3.89e-05	0.000439	CcSEcCtD
Timolol—Decreased appetite—Metformin—type 2 diabetes mellitus	3.89e-05	0.000439	CcSEcCtD
Timolol—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.88e-05	0.000438	CcSEcCtD
Timolol—Nausea—Bromocriptine—type 2 diabetes mellitus	3.87e-05	0.000436	CcSEcCtD
Timolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.86e-05	0.000436	CcSEcCtD
Timolol—Fatigue—Metformin—type 2 diabetes mellitus	3.85e-05	0.000435	CcSEcCtD
Timolol—Urticaria—Orlistat—type 2 diabetes mellitus	3.85e-05	0.000435	CcSEcCtD
Timolol—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.84e-05	0.000434	CcSEcCtD
Timolol—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.84e-05	0.000433	CcSEcCtD
Timolol—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.83e-05	0.000433	CcSEcCtD
Timolol—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.83e-05	0.000433	CcSEcCtD
Timolol—Asthenia—Gliclazide—type 2 diabetes mellitus	3.83e-05	0.000433	CcSEcCtD
Timolol—Angioedema—Ramipril—type 2 diabetes mellitus	3.81e-05	0.00043	CcSEcCtD
Timolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.79e-05	0.000427	CcSEcCtD
Timolol—Anorexia—Losartan—type 2 diabetes mellitus	3.78e-05	0.000427	CcSEcCtD
Timolol—Vomiting—Glyburide—type 2 diabetes mellitus	3.78e-05	0.000427	CcSEcCtD
Timolol—Pruritus—Gliclazide—type 2 diabetes mellitus	3.78e-05	0.000427	CcSEcCtD
Timolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.76e-05	0.000424	CcSEcCtD
Timolol—Rash—Glyburide—type 2 diabetes mellitus	3.75e-05	0.000423	CcSEcCtD
Timolol—Somnolence—Irbesartan—type 2 diabetes mellitus	3.75e-05	0.000423	CcSEcCtD
Timolol—Dermatitis—Glyburide—type 2 diabetes mellitus	3.75e-05	0.000423	CcSEcCtD
Timolol—Vertigo—Ramipril—type 2 diabetes mellitus	3.75e-05	0.000423	CcSEcCtD
Timolol—Syncope—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000422	CcSEcCtD
Timolol—Headache—Glyburide—type 2 diabetes mellitus	3.73e-05	0.000421	CcSEcCtD
Timolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.71e-05	0.000419	CcSEcCtD
Timolol—Hypotension—Losartan—type 2 diabetes mellitus	3.71e-05	0.000419	CcSEcCtD
Timolol—Palpitations—Ramipril—type 2 diabetes mellitus	3.69e-05	0.000416	CcSEcCtD
Timolol—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.68e-05	0.000416	CcSEcCtD
Timolol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.67e-05	0.000414	CcSEcCtD
Timolol—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.67e-05	0.000414	CcSEcCtD
Timolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.66e-05	0.000413	CcSEcCtD
Timolol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.66e-05	0.000412	CcSEcCtD
Timolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.000411	CcSEcCtD
Timolol—Cough—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000411	CcSEcCtD
Timolol—Fatigue—Irbesartan—type 2 diabetes mellitus	3.64e-05	0.00041	CcSEcCtD
Timolol—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.62e-05	0.000408	CcSEcCtD
Timolol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.62e-05	0.000408	CcSEcCtD
Timolol—Pain—Irbesartan—type 2 diabetes mellitus	3.61e-05	0.000407	CcSEcCtD
Timolol—Insomnia—Losartan—type 2 diabetes mellitus	3.59e-05	0.000405	CcSEcCtD
Timolol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000403	CcSEcCtD
Timolol—Paraesthesia—Losartan—type 2 diabetes mellitus	3.56e-05	0.000402	CcSEcCtD
Timolol—Urticaria—Metformin—type 2 diabetes mellitus	3.55e-05	0.000401	CcSEcCtD
Timolol—Chest pain—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000401	CcSEcCtD
Timolol—Myalgia—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000401	CcSEcCtD
Timolol—Arthralgia—Ramipril—type 2 diabetes mellitus	3.55e-05	0.000401	CcSEcCtD
Timolol—Dyspnoea—Losartan—type 2 diabetes mellitus	3.54e-05	0.000399	CcSEcCtD
Timolol—Anxiety—Ramipril—type 2 diabetes mellitus	3.54e-05	0.000399	CcSEcCtD
Timolol—Nausea—Glyburide—type 2 diabetes mellitus	3.53e-05	0.000399	CcSEcCtD
Timolol—Abdominal pain—Metformin—type 2 diabetes mellitus	3.53e-05	0.000399	CcSEcCtD
Timolol—Dizziness—Gliclazide—type 2 diabetes mellitus	3.53e-05	0.000399	CcSEcCtD
Timolol—Somnolence—Losartan—type 2 diabetes mellitus	3.53e-05	0.000398	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000398	CcSEcCtD
Timolol—Asthenia—Valsartan—type 2 diabetes mellitus	3.52e-05	0.000397	CcSEcCtD
Timolol—Discomfort—Ramipril—type 2 diabetes mellitus	3.51e-05	0.000396	CcSEcCtD
Timolol—Dyspepsia—Losartan—type 2 diabetes mellitus	3.49e-05	0.000394	CcSEcCtD
Timolol—Asthenia—Orlistat—type 2 diabetes mellitus	3.48e-05	0.000393	CcSEcCtD
Timolol—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.48e-05	0.000392	CcSEcCtD
Timolol—Pruritus—Valsartan—type 2 diabetes mellitus	3.47e-05	0.000392	CcSEcCtD
Timolol—Dry mouth—Ramipril—type 2 diabetes mellitus	3.47e-05	0.000392	CcSEcCtD
Timolol—Decreased appetite—Losartan—type 2 diabetes mellitus	3.45e-05	0.000389	CcSEcCtD
Timolol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.45e-05	0.000389	CcSEcCtD
Timolol—Confusional state—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000387	CcSEcCtD
Timolol—Pruritus—Orlistat—type 2 diabetes mellitus	3.43e-05	0.000387	CcSEcCtD
Timolol—Fatigue—Losartan—type 2 diabetes mellitus	3.42e-05	0.000386	CcSEcCtD
Timolol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000384	CcSEcCtD
Timolol—Oedema—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000384	CcSEcCtD
Timolol—Vomiting—Gliclazide—type 2 diabetes mellitus	3.4e-05	0.000383	CcSEcCtD
Timolol—Pain—Losartan—type 2 diabetes mellitus	3.39e-05	0.000383	CcSEcCtD
Timolol—Rash—Gliclazide—type 2 diabetes mellitus	3.37e-05	0.00038	CcSEcCtD
Timolol—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.37e-05	0.00038	CcSEcCtD
Timolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.36e-05	0.000379	CcSEcCtD
Timolol—Urticaria—Irbesartan—type 2 diabetes mellitus	3.35e-05	0.000378	CcSEcCtD
Timolol—Shock—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000378	CcSEcCtD
Timolol—Headache—Gliclazide—type 2 diabetes mellitus	3.35e-05	0.000378	CcSEcCtD
Timolol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.34e-05	0.000377	CcSEcCtD
Timolol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.33e-05	0.000376	CcSEcCtD
Timolol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.33e-05	0.000376	CcSEcCtD
Timolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.32e-05	0.000375	CcSEcCtD
Timolol—Skin disorder—Ramipril—type 2 diabetes mellitus	3.31e-05	0.000373	CcSEcCtD
Timolol—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.29e-05	0.000371	CcSEcCtD
Timolol—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.27e-05	0.000369	CcSEcCtD
Timolol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.25e-05	0.000366	CcSEcCtD
Timolol—Dizziness—Valsartan—type 2 diabetes mellitus	3.25e-05	0.000366	CcSEcCtD
Timolol—Anorexia—Ramipril—type 2 diabetes mellitus	3.24e-05	0.000366	CcSEcCtD
Timolol—Dizziness—Orlistat—type 2 diabetes mellitus	3.21e-05	0.000362	CcSEcCtD
Timolol—Asthenia—Metformin—type 2 diabetes mellitus	3.21e-05	0.000362	CcSEcCtD
Timolol—Hypotension—Ramipril—type 2 diabetes mellitus	3.18e-05	0.000359	CcSEcCtD
Timolol—Nausea—Gliclazide—type 2 diabetes mellitus	3.17e-05	0.000358	CcSEcCtD
Timolol—Pruritus—Metformin—type 2 diabetes mellitus	3.16e-05	0.000357	CcSEcCtD
Timolol—Urticaria—Losartan—type 2 diabetes mellitus	3.15e-05	0.000356	CcSEcCtD
Timolol—Abdominal pain—Losartan—type 2 diabetes mellitus	3.14e-05	0.000354	CcSEcCtD
Timolol—Body temperature increased—Losartan—type 2 diabetes mellitus	3.14e-05	0.000354	CcSEcCtD
Timolol—Vomiting—Valsartan—type 2 diabetes mellitus	3.12e-05	0.000352	CcSEcCtD
Timolol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.11e-05	0.000351	CcSEcCtD
Timolol—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.1e-05	0.00035	CcSEcCtD
Timolol—Rash—Valsartan—type 2 diabetes mellitus	3.1e-05	0.000349	CcSEcCtD
Timolol—Dermatitis—Valsartan—type 2 diabetes mellitus	3.09e-05	0.000349	CcSEcCtD
Timolol—Vomiting—Orlistat—type 2 diabetes mellitus	3.08e-05	0.000348	CcSEcCtD
Timolol—Insomnia—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000347	CcSEcCtD
Timolol—Headache—Valsartan—type 2 diabetes mellitus	3.08e-05	0.000347	CcSEcCtD
Timolol—Diarrhoea—Metformin—type 2 diabetes mellitus	3.06e-05	0.000345	CcSEcCtD
Timolol—Rash—Orlistat—type 2 diabetes mellitus	3.06e-05	0.000345	CcSEcCtD
Timolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.06e-05	0.000345	CcSEcCtD
Timolol—Dermatitis—Orlistat—type 2 diabetes mellitus	3.06e-05	0.000345	CcSEcCtD
Timolol—Headache—Orlistat—type 2 diabetes mellitus	3.04e-05	0.000343	CcSEcCtD
Timolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000342	CcSEcCtD
Timolol—Asthenia—Irbesartan—type 2 diabetes mellitus	3.03e-05	0.000342	CcSEcCtD
Timolol—Somnolence—Ramipril—type 2 diabetes mellitus	3.03e-05	0.000342	CcSEcCtD
Timolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	3e-05	0.000338	CcSEcCtD
Timolol—Pruritus—Irbesartan—type 2 diabetes mellitus	2.98e-05	0.000337	CcSEcCtD
Timolol—Decreased appetite—Ramipril—type 2 diabetes mellitus	2.96e-05	0.000334	CcSEcCtD
Timolol—Dizziness—Metformin—type 2 diabetes mellitus	2.96e-05	0.000334	CcSEcCtD
Timolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	2.94e-05	0.000332	CcSEcCtD
Timolol—Fatigue—Ramipril—type 2 diabetes mellitus	2.93e-05	0.000331	CcSEcCtD
Timolol—Hypersensitivity—Losartan—type 2 diabetes mellitus	2.92e-05	0.00033	CcSEcCtD
Timolol—Nausea—Valsartan—type 2 diabetes mellitus	2.92e-05	0.000329	CcSEcCtD
Timolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.89e-05	0.000326	CcSEcCtD
Timolol—Nausea—Orlistat—type 2 diabetes mellitus	2.88e-05	0.000325	CcSEcCtD
Timolol—Asthenia—Losartan—type 2 diabetes mellitus	2.85e-05	0.000321	CcSEcCtD
Timolol—Vomiting—Metformin—type 2 diabetes mellitus	2.84e-05	0.000321	CcSEcCtD
Timolol—Rash—Metformin—type 2 diabetes mellitus	2.82e-05	0.000318	CcSEcCtD
Timolol—Dermatitis—Metformin—type 2 diabetes mellitus	2.82e-05	0.000318	CcSEcCtD
Timolol—Pruritus—Losartan—type 2 diabetes mellitus	2.81e-05	0.000317	CcSEcCtD
Timolol—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.81e-05	0.000317	CcSEcCtD
Timolol—Headache—Metformin—type 2 diabetes mellitus	2.8e-05	0.000316	CcSEcCtD
Timolol—Dizziness—Irbesartan—type 2 diabetes mellitus	2.79e-05	0.000315	CcSEcCtD
Timolol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.78e-05	0.000314	CcSEcCtD
Timolol—Diarrhoea—Losartan—type 2 diabetes mellitus	2.72e-05	0.000307	CcSEcCtD
Timolol—Urticaria—Ramipril—type 2 diabetes mellitus	2.7e-05	0.000305	CcSEcCtD
Timolol—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000304	CcSEcCtD
Timolol—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.69e-05	0.000304	CcSEcCtD
Timolol—Vomiting—Irbesartan—type 2 diabetes mellitus	2.68e-05	0.000303	CcSEcCtD
Timolol—Rash—Irbesartan—type 2 diabetes mellitus	2.66e-05	0.0003	CcSEcCtD
Timolol—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.66e-05	0.0003	CcSEcCtD
Timolol—Nausea—Metformin—type 2 diabetes mellitus	2.66e-05	0.0003	CcSEcCtD
Timolol—Headache—Irbesartan—type 2 diabetes mellitus	2.64e-05	0.000298	CcSEcCtD
Timolol—Dizziness—Losartan—type 2 diabetes mellitus	2.63e-05	0.000296	CcSEcCtD
Timolol—Vomiting—Losartan—type 2 diabetes mellitus	2.52e-05	0.000285	CcSEcCtD
Timolol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.51e-05	0.000283	CcSEcCtD
Timolol—Nausea—Irbesartan—type 2 diabetes mellitus	2.51e-05	0.000283	CcSEcCtD
Timolol—Rash—Losartan—type 2 diabetes mellitus	2.5e-05	0.000282	CcSEcCtD
Timolol—Dermatitis—Losartan—type 2 diabetes mellitus	2.5e-05	0.000282	CcSEcCtD
Timolol—Headache—Losartan—type 2 diabetes mellitus	2.49e-05	0.000281	CcSEcCtD
Timolol—Asthenia—Ramipril—type 2 diabetes mellitus	2.44e-05	0.000276	CcSEcCtD
Timolol—Pruritus—Ramipril—type 2 diabetes mellitus	2.41e-05	0.000272	CcSEcCtD
Timolol—Nausea—Losartan—type 2 diabetes mellitus	2.36e-05	0.000266	CcSEcCtD
Timolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.33e-05	0.000263	CcSEcCtD
Timolol—Dizziness—Ramipril—type 2 diabetes mellitus	2.25e-05	0.000254	CcSEcCtD
Timolol—Vomiting—Ramipril—type 2 diabetes mellitus	2.16e-05	0.000244	CcSEcCtD
Timolol—Rash—Ramipril—type 2 diabetes mellitus	2.15e-05	0.000242	CcSEcCtD
Timolol—Dermatitis—Ramipril—type 2 diabetes mellitus	2.14e-05	0.000242	CcSEcCtD
Timolol—Headache—Ramipril—type 2 diabetes mellitus	2.13e-05	0.000241	CcSEcCtD
Timolol—Nausea—Ramipril—type 2 diabetes mellitus	2.02e-05	0.000228	CcSEcCtD
Timolol—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.3e-06	0.000129	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.29e-06	0.000129	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC2A2—type 2 diabetes mellitus	4.27e-06	0.000128	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	4.24e-06	0.000127	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AVP—type 2 diabetes mellitus	4.24e-06	0.000127	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.24e-06	0.000127	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.22e-06	0.000126	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GLP1R—type 2 diabetes mellitus	4.21e-06	0.000126	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—GNB3—type 2 diabetes mellitus	4.2e-06	0.000126	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.2e-06	0.000126	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MTR—type 2 diabetes mellitus	4.19e-06	0.000125	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CPT1A—type 2 diabetes mellitus	4.19e-06	0.000125	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	4.17e-06	0.000125	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.16e-06	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP3—type 2 diabetes mellitus	4.14e-06	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AVP—type 2 diabetes mellitus	4.14e-06	0.000124	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.14e-06	0.000124	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.14e-06	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF2—type 2 diabetes mellitus	4.13e-06	0.000124	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	4.11e-06	0.000123	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NAMPT—type 2 diabetes mellitus	4.11e-06	0.000123	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APOB—type 2 diabetes mellitus	4.09e-06	0.000123	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	4.09e-06	0.000122	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	4.09e-06	0.000122	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.08e-06	0.000122	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GCK—type 2 diabetes mellitus	4.08e-06	0.000122	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HBA1—type 2 diabetes mellitus	4.08e-06	0.000122	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—LIPC—type 2 diabetes mellitus	4.08e-06	0.000122	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	4.08e-06	0.000122	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	4.07e-06	0.000122	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP11A1—type 2 diabetes mellitus	4.06e-06	0.000121	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EDN1—type 2 diabetes mellitus	4.03e-06	0.000121	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	4.01e-06	0.00012	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APOB—type 2 diabetes mellitus	4.01e-06	0.00012	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	3.99e-06	0.000119	CbGpPWpGaD
Timolol—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	3.98e-06	0.000119	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC9A1—type 2 diabetes mellitus	3.98e-06	0.000119	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	3.98e-06	0.000119	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	3.98e-06	0.000119	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	3.96e-06	0.000119	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EDN1—type 2 diabetes mellitus	3.94e-06	0.000118	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CETP—type 2 diabetes mellitus	3.94e-06	0.000118	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC2A2—type 2 diabetes mellitus	3.93e-06	0.000118	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LPL—type 2 diabetes mellitus	3.91e-06	0.000117	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RELA—type 2 diabetes mellitus	3.89e-06	0.000117	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	3.89e-06	0.000116	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CPT1A—type 2 diabetes mellitus	3.85e-06	0.000115	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTR—type 2 diabetes mellitus	3.85e-06	0.000115	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	3.84e-06	0.000115	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.83e-06	0.000115	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LPL—type 2 diabetes mellitus	3.82e-06	0.000115	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NAMPT—type 2 diabetes mellitus	3.78e-06	0.000113	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	3.77e-06	0.000113	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HBA1—type 2 diabetes mellitus	3.75e-06	0.000112	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—LIPC—type 2 diabetes mellitus	3.75e-06	0.000112	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GCK—type 2 diabetes mellitus	3.75e-06	0.000112	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	3.74e-06	0.000112	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP11A1—type 2 diabetes mellitus	3.73e-06	0.000112	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.67e-06	0.00011	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.67e-06	0.00011	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC9A1—type 2 diabetes mellitus	3.66e-06	0.00011	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PSMD6—type 2 diabetes mellitus	3.66e-06	0.00011	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SREBF1—type 2 diabetes mellitus	3.66e-06	0.00011	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SNAP25—type 2 diabetes mellitus	3.66e-06	0.00011	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CETP—type 2 diabetes mellitus	3.62e-06	0.000108	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.6e-06	0.000108	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CTGF—type 2 diabetes mellitus	3.59e-06	0.000108	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	3.59e-06	0.000107	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	3.57e-06	0.000107	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	3.57e-06	0.000107	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	3.57e-06	0.000107	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	3.56e-06	0.000107	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.54e-06	0.000106	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCR5—type 2 diabetes mellitus	3.52e-06	0.000106	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—C3—type 2 diabetes mellitus	3.52e-06	0.000105	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.51e-06	0.000105	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.51e-06	0.000105	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	3.51e-06	0.000105	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.49e-06	0.000104	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	3.48e-06	0.000104	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	3.48e-06	0.000104	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—C3—type 2 diabetes mellitus	3.44e-06	0.000103	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.41e-06	0.000102	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	3.4e-06	0.000102	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	3.37e-06	0.000101	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	3.37e-06	0.000101	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	3.37e-06	0.000101	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.36e-06	0.000101	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.35e-06	0.0001	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	3.35e-06	0.0001	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AGT—type 2 diabetes mellitus	3.35e-06	0.0001	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.32e-06	9.94e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	3.31e-06	9.91e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	3.31e-06	9.91e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	3.3e-06	9.9e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.29e-06	9.85e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	3.28e-06	9.83e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.28e-06	9.83e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LEP—type 2 diabetes mellitus	3.28e-06	9.81e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APOE—type 2 diabetes mellitus	3.28e-06	9.81e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IRS2—type 2 diabetes mellitus	3.28e-06	9.81e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	3.28e-06	9.81e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AGT—type 2 diabetes mellitus	3.27e-06	9.8e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	3.27e-06	9.79e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.24e-06	9.7e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	3.23e-06	9.68e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	3.23e-06	9.68e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	3.23e-06	9.67e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.22e-06	9.64e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.22e-06	9.63e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.21e-06	9.62e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LEP—type 2 diabetes mellitus	3.21e-06	9.6e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APOE—type 2 diabetes mellitus	3.21e-06	9.6e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	3.21e-06	9.6e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.17e-06	9.5e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.17e-06	9.5e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.17e-06	9.49e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	3.15e-06	9.44e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	3.1e-06	9.28e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	3.1e-06	9.28e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.09e-06	9.25e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.08e-06	9.22e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SRC—type 2 diabetes mellitus	3.06e-06	9.16e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.04e-06	9.12e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.04e-06	9.12e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.02e-06	9.05e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.98e-06	8.92e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.97e-06	8.89e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.92e-06	8.75e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.92e-06	8.74e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.92e-06	8.74e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.86e-06	8.56e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—INS—type 2 diabetes mellitus	2.8e-06	8.38e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.75e-06	8.25e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—INS—type 2 diabetes mellitus	2.74e-06	8.2e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.74e-06	8.19e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.74e-06	8.19e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.74e-06	8.19e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.72e-06	8.15e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.71e-06	8.11e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.71e-06	8.1e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.69e-06	8.07e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.69e-06	8.07e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.69e-06	8.05e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.68e-06	8.03e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.67e-06	8e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.67e-06	8e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.66e-06	7.96e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.65e-06	7.93e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.65e-06	7.93e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	2.64e-06	7.89e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.62e-06	7.85e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.61e-06	7.81e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.57e-06	7.7e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.55e-06	7.62e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.54e-06	7.6e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.52e-06	7.53e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.52e-06	7.53e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.52e-06	7.53e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.5e-06	7.5e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.49e-06	7.46e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.48e-06	7.42e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.47e-06	7.4e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.46e-06	7.35e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.46e-06	7.35e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.44e-06	7.3e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.43e-06	7.28e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.43e-06	7.28e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.4e-06	7.19e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.4e-06	7.19e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.4e-06	7.18e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.38e-06	7.13e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.37e-06	7.1e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.37e-06	7.09e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.34e-06	7e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.33e-06	6.99e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	2.31e-06	6.92e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.31e-06	6.92e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.29e-06	6.86e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.28e-06	6.83e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	2.26e-06	6.77e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.24e-06	6.72e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.24e-06	6.71e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.23e-06	6.69e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.2e-06	6.59e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.19e-06	6.55e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.18e-06	6.52e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.15e-06	6.44e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.15e-06	6.43e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.13e-06	6.38e-05	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.1e-06	6.3e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.1e-06	6.27e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.09e-06	6.25e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.08e-06	6.24e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	2.08e-06	6.23e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.07e-06	6.2e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.06e-06	6.18e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.06e-06	6.18e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	2.06e-06	6.17e-05	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.06e-06	6.16e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	2.04e-06	6.12e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.04e-06	6.11e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	2.04e-06	6.1e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.03e-06	6.07e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.02e-06	6.06e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	2.01e-06	6.03e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.97e-06	5.9e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.96e-06	5.87e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.95e-06	5.84e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.93e-06	5.77e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.93e-06	5.77e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.92e-06	5.75e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.91e-06	5.72e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.91e-06	5.71e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.9e-06	5.69e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.9e-06	5.68e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.87e-06	5.6e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.82e-06	5.44e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.82e-06	5.44e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.78e-06	5.34e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.78e-06	5.32e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.77e-06	5.31e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.77e-06	5.3e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.74e-06	5.21e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.73e-06	5.18e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.67e-06	5.01e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.64e-06	4.91e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.64e-06	4.9e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.62e-06	4.86e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.6e-06	4.78e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.59e-06	4.77e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.59e-06	4.76e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.56e-06	4.68e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.56e-06	4.68e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.56e-06	4.66e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.53e-06	4.57e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.53e-06	4.57e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.5e-06	4.5e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.44e-06	4.31e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.44e-06	4.31e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.43e-06	4.28e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.4e-06	4.18e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.32e-06	3.94e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	1.22e-06	3.66e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.2e-06	3.58e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.13e-06	3.38e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.1e-06	3.31e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	7.19e-07	2.15e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	7.02e-07	2.1e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.61e-07	1.98e-05	CbGpPWpGaD
